Safety and Efficacy of Inhaled Insulin in Type 2 Diabetes
Status:
Terminated
Trial end date:
2008-05-05
Target enrollment:
Participant gender:
Summary
This trial is conducted in Asia, Europe and South America. The aim of this research is to
compare the efficacy (reduction in HbA1c and blood glucose) and pulmonary safety (pulmonary
function tests, chest x-rays) of mealtime inhaled insulin with subcutaneous insulin aspart
both in combination with insulin detemir in Type 2 Diabetes.